Monensin Improves the Effectiveness of meso -Dimercaptosuccinate when Used to Treat Lead Intoxication in Rats
Open Access
- 1 April 2006
- journal article
- Published by American Chemical Society (ACS) in Environmental Health Perspectives
- Vol. 114 (4) , 484-493
Abstract
Among divalent cations, the ionophore monensin shows high activity and selectivity for the transport of lead ions (Pb2+) across phospholipid membranes. When coadministered to rats that were receiving meso-dimercaptosuccinate for treatment of Pb intoxication, monensin significantly increased the amount of Pb removed from femur, brain, and heart. It showed a tendency to increase Pb removal from liver and kidney but had no effect of this type in skeletal muscle. Tissue levels of several physiologic (calcium, cobalt, copper, iron, magnesium, manganese, molybdenum, zinc) and nonphysiologic (arsenic, cadmium, chromium, nickel, strontium) elements were also determined after the application of these compounds. Among the physiologic elements, a number of significant changes were seen, including both rising and falling values. The size of these changes was typically around 20% compared with control values, with the largest examples seen in femur. These changes often tended to reverse those of similar size that had occurred during Pb administration. Among the nonphysiologic elements, which were present in trace amounts, the changes were smaller in number but larger in size. None of these changes appears likely to be significant in terms of toxicity, and there were no signs of overt toxicity under any of the conditions employed. Monensin may act by cotransporting Pb2+ and OH– ions out of cells, in exchange for external sodium ions. The net effect would be to shuttle intracellular Pb2+ to extracellular dimercaptosuccinic acid thereby enhancing its effectiveness. Thus, monensin may be useful for the treatment of Pb intoxication when applied in combination with hydrophilic Pb2+ chelators.Keywords
This publication has 49 references indexed in Scilit:
- Monensin Mediates a Rapid and Selective Transport of Pb2+Journal of Biological Chemistry, 2002
- Combined chelation therapy in reducing tissue lead concentrations in suckling ratsJournal of Applied Toxicology, 1999
- Comparativein vivoLead Mobilization ofmeso‐ andrac‐2,3‐Dimercaptosuccinic Acids in Albino Wistar RatsBasic & Clinical Pharmacology & Toxicology, 1997
- Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals.Environmental Health Perspectives, 1995
- Complexation chemistry of ionophores A23187 and ionomycinPure and Applied Chemistry, 1993
- Chelation in metal intoxication: XXXIV. Mixed ligand chelation in lead poisoningToxicology Letters, 1991
- Calcium modulation of mitochondrial inner membrane channel activityBiochemical and Biophysical Research Communications, 1991
- Treatment of acute lead intoxication. A quantitative comparison of a number of chelating agentsArchives of Environmental Contamination and Toxicology, 1990
- Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrationsThe Journal of Pediatrics, 1988
- Effect of membrane association on the stability of complexes between ionophore A23187 and monovalent cationsBiochemistry, 1985